⭐️⭐️⭐️⭐️⭐️ "A total no brainer"

⭐️⭐️⭐️⭐️⭐️ "Love this, so easy."

Spots is the easy way to track your skin, mole and cancer changes.

Spots Global Cancer Trial Database for MR Guided Focused Ultrasound Surgery in the Treatment of Breast Fibroadenomas

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Trial Identification

Brief Title: MR Guided Focused Ultrasound Surgery in the Treatment of Breast Fibroadenomas

Official Title: Phase 3 Study of MR Guided Focused Ultrasound Surgery in the Treatment of Breast Fibroadenomas

Study ID: NCT00147108

Interventions

ExAblate 2000

Study Description

Brief Summary: The primary objective of this pivotal study is to evaluate the safety and efficacy of FUS treatment of breast fibroadenomas. Our hypothesis is that FUS lesion ablation of a fibroadenoma will have the following results: a. lead to a decrease in lesion cross-sectional area of \> 50% on palpation, and \>65% in lesion volume as measured by MRI (both calculations assume an elliptical shape of the lesion in all 3 dimensions). b. this decrease in size, along with the softening of the treated volume will result in satisfactory clinical results in greater than 50 % of the patients.

Detailed Description: Many patients are now diagnosed with breast fibroadenomas. These are generally detected during breast self-exams, or annual physicals as a smooth, rubbery, oval/elliptical lump in the breast. These patients then go on to receive mammograms, sonograms and usually a core biopsy for the differential diagnosis of benign disease (fibroadenoma) vs breast cancer. Although fibroadenomas are benign, they can be of great concern to the patient because of their ability to mask the presence of other lumps in the breast, they can be painful, cause a physical deformity of the breast or have other symptoms. The current treatment is surgical excision. Surgical removal is invasive and may be cosmetically undesirable to some patients. It would be advantageous to develop a non-invasive ablative method for treatment of this disease. Measures of the clinical success of patients who elect surgical removal of fibroadenomas are generally subjective, and evaluated primarily by the patient (lack of palpable lesion, pain free, and an acceptable cosmetic result). A non-randomized study is proposed to allow for a more practical approach in subject recruitment. Analysis on safety and efficacy will be performed through the use of MRI evaluation and physical exams.

Eligibility

Minimum Age: 18 Years

Eligible Ages: ADULT, OLDER_ADULT

Sex: FEMALE

Healthy Volunteers: Yes

Locations

University MRI, Boca Raton, Florida, United States

Brigham & Women's Hospital, Boston, Massachusetts, United States

Virtua, Voorhees, New Jersey, United States

Cornell Vascular, New York, New York, United States

Breastopia Namba Hospital, Miyazaki-ken, , Japan

Contact Details

Name: Clare Tempany, M.D.

Affiliation: Brigham and Women's Hospital

Role: PRINCIPAL_INVESTIGATOR

Name: Robert Min, M.D.

Affiliation: Cornell Vascular

Role: PRINCIPAL_INVESTIGATOR

Name: Fred Steinberg, M.D.

Affiliation: University MRI

Role: PRINCIPAL_INVESTIGATOR

Name: Mark DeLaurentis, M.D.

Affiliation: Virtua

Role: PRINCIPAL_INVESTIGATOR

Name: Hidemi Furusawa, M.D.

Affiliation: Breastopia Hospital

Role: PRINCIPAL_INVESTIGATOR

Useful links and downloads for this trial

Clinicaltrials.gov

Google Search Results

Logo

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

spots app storespots app store

Join others from around the world: